PHARMACEUTICAL PREPARATIONS FOR HUMAN USE

Brand Owner (click to sort) Address Description
AMINODEX PHARMACIA LABORATORIES, INC. Piscataway NJ PHARMACEUTICAL PREPARATIONS FOR HUMAN USE CONTAINING AMINO ACIDS AND HAVING UNTRITIVE VALUE WHEN PARENTERALLY ADMINISTERED;
GLAXO ZANTAC GLAXO GROUP LIMITED 980 Great West Road Brentford, Middlesex TW89GS PHARMACEUTICAL PREPARATIONS FOR HUMAN USE BEING GASTRIC FLUID INHIBITORS;
GLYZAC MONSANTO COMPANY 800 N. LINDBERGH BLVD., E2NA ST. LOUIS MO 63167 PHARMACEUTICAL PREPARATIONS FOR HUMAN USE WHICH IS ACTIVE UPON THE CENTRAL NERVOUS SYSTEM;
L LOREX Synthelabo Paris France PHARMACEUTICAL PREPARATIONS FOR HUMAN USE, NAMELY, PREPARATIONS FOR THE TREATMENT OF DISORDERS OF THE CENTRAL NERVOUS SYSTEM AND OF THE CARDIO-VASCULAR SYSTEM;
MUCOTIAZIL CAMILLO CORVI S.P.A. VIA S. MARCO 18, MILAN Italy PHARMACEUTICAL PREPARATIONS FOR HUMAN USE IN THE TREATMENT OF BRONCHOPNEUMONAL DISEASES, NAMELY--CHEMOTHERAPEUTIC AND ANTIASTHMATIC PHARMACEUTICALS;
OM LABORATOIRES OM S.A. 22, RUE DU BOIS-DU-LAN 1217 MEYRIN 2, GENEVA Switzerland PHARMACEUTICAL PREPARATIONS FOR HUMAN USE, NAMELY HEMOSTATIC, CARDIOVASCULAR, ANTIHEMORRHOIDAL, ANGIOPROTECTING, ANTILIPEMIC AND IMMUNOSTIMULANTS AND VACCINES, EXCLUDING PHARMACEUTICAL PREPARATIONS CONTAINING MILK OF MAGNESIA AND MINERAL OIL;
SULOCTON MONSANTO COMPANY 800 N. LINDBERGH BLVD., E2NA ST. LOUIS MO 63167 PHARMACEUTICAL PREPARATIONS FOR HUMAN USE WHICH IMPROVES THE FUNCTION OF THE VASCULA AND THE BLOOD FLOW;
ZANTAC CHATTEM, INC. 1715 West 38th Street Chattanooga TN 37409 Pharmaceutical Preparations for Human Use Being Gastric Fluid Inhibitors;
ZANTAC GLAXO GROUP LIMITED 980 Great West Road Brentford, Middlesex TW89GS Pharmaceutical Preparations for Human Use Being Gastric Fluid Inhibitors;The drawing is lined for the color blue, and color is specifically claimed.;
 

Where the owner name is not linked, that owner no longer owns the brand

   
Technical Examples
  1. The invention provides compositions, pharmaceutical preparations and methods for inhibition of cystic fibrosis transmembrane conductance regulator protein (CFTR) that are useful for treating secretory diarrhea. The compositions and pharmaceutical preparations of the invention may comprise one or more thiazolidinone compounds, and may additionally comprise one or more pharmaceutically acceptable carriers, excipients, and/or diluents.